253 related articles for article (PubMed ID: 22275826)
1. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.
Ortiz R; Prados J; Melguizo C; Arias JL; Ruiz MA; Alvarez PJ; Caba O; Luque R; Segura A; Aránega A
Int J Nanomedicine; 2012; 7():95-107. PubMed ID: 22275826
[TBL] [Abstract][Full Text] [Related]
2. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.
Ortiz R; Cabeza L; Arias JL; Melguizo C; Álvarez PJ; Vélez C; Clares B; Áranega A; Prados J
AAPS J; 2015 Jul; 17(4):918-29. PubMed ID: 25894746
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles.
Russo A; Maiolino S; Pagliara V; Ungaro F; Tatangelo F; Leone A; Scalia G; Budillon A; Quaglia F; Russo G
Oncotarget; 2016 Nov; 7(48):79670-79687. PubMed ID: 27835895
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
5. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
6. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
7. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
[TBL] [Abstract][Full Text] [Related]
9. Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells.
Abd-Rabou AA; Shalby AB; Ahmed HH
Biol Trace Elem Res; 2019 Jan; 187(1):80-91. PubMed ID: 29748931
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment.
Anitha A; Deepa N; Chennazhi KP; Lakshmanan VK; Jayakumar R
Biochim Biophys Acta; 2014 Sep; 1840(9):2730-43. PubMed ID: 24946270
[TBL] [Abstract][Full Text] [Related]
11. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil.
Ashour AE; Badran MM; Kumar A; Rishi AK; Yassin AE
IEEE Trans Nanobioscience; 2016 Oct; 15(7):739-747. PubMed ID: 28029617
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
[TBL] [Abstract][Full Text] [Related]
13. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
Yun S; Han YS; Lee JH; Kim S; Lee SH
Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
[TBL] [Abstract][Full Text] [Related]
15. Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.
Cheng MR; Li Q; Wan T; He B; Han J; Chen HX; Yang FX; Wang W; Xu HZ; Ye T; Zha BB
World J Gastroenterol; 2012 Nov; 18(42):6076-87. PubMed ID: 23155336
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers.
Wang Z; Wei Y; Fang G; Hong D; An L; Jiao T; Shi Y; Zang A
Drug Des Devel Ther; 2018; 12():3171-3180. PubMed ID: 30288022
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
[TBL] [Abstract][Full Text] [Related]
18. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
[TBL] [Abstract][Full Text] [Related]
19. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
20. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]